Guido Koch PhD, MS

Guido Koch is currently working as a Chief Executive Officer at Amphilix Basel, Switzerland. Dr. Guido Koch holds the position of COO at Topadur Pharma AG, a Swiss Biotech company focusing on the discovery and development of innovative medicines for the treatment of severe wounds. Until January 2018, Guido was a Director in Global Discovery Chemistry at Novartis Institutes for Biomedical Research in Basel. The focus of his research team was to enable challenging chemistry and apply innovative synthesis design for fast and high-quality lead optimization.